Latest stock market news videos & Morning Bell

From the helm: Starpharma’s (ASX:SPL) Chief Executive Officer, Dr. Jackie Fairley

Bell Direct
November 8, 2022

In this instalment of our From the helm series, Bell Direct’s Grady Wulff speaks to Starpharma’s (ASX:SPL) Chief Executive Officer, Dr. Jackie Fairley.
 
Starpharma Holdings Limited (ASX:SPL) is a global biopharmaceutical company and a world leader in the development of new pharmaceutical and medical products based on proprietary polymers called dendrimers. In this video Dr. Fairley discusses:

  • (0:56) A brief overview of Starpharma
  • (2:31) Growing distribution network for Viraleze
  • (3:29) SPL’s exciting oncology portfolio and key partnerships with major companies
  • (4:56) How Viraleze works and the market opportunity going forward
  • (6:09) What’s coming up next for SPL

Note: This interview was filmed on 20 October 2022.

Looking at the financial year ahead

Bell Direct
June 29, 2017

XTBs

Bell Direct
May 17, 2017

April Overview

Bell Direct
April 26, 2017

March Overview

Bell Direct
March 30, 2017

Weekly wrap 24 March

Bell Direct
March 24, 2017

February newsletter Julia’s insights

Bell Direct
February 24, 2017

Weekly Wrap 17 February

Bell Direct
February 24, 2017

Weekly Wrap 10 February

Bell Direct
February 10, 2017

Weekly wrap 3 February

Bell Direct
February 3, 2017